FDA Inspection
Newborn Blood Banking, Inc.Newborn Blood Banking, Inc. – FDA Inspection, Jun 11, 2013
Record Details
This FDA Inspection record concerns Newborn Blood Banking, Inc., with an inspection on June 11, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Newborn Blood Banking, Inc.
- Inspection Date
- June 11, 2013
- Product Type
- Biologics
View Company Profile
ID · a8f4f483-bcc7-41b4-84eb-05436b28c3db
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 834831
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Newborn Blood Banking, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2009 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Newborn Blood Banking, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.